- Home
- Publications
- Publication Search
- Publication Details
Title
Ebselen, a new candidate therapeutic against SARS-CoV-2
Authors
Keywords
Main protease, Clinical trials, COVID-19, SARS-CoV-2, Ebselen, Therapeutics, Repurposed drug
Journal
International Journal of Surgery
Volume 84, Issue -, Pages 53-56
Publisher
Elsevier BV
Online
2020-10-24
DOI
10.1016/j.ijsu.2020.10.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- H2S as a potential defense against COVID-19?
- (2020) Guangdong Yang AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections
- (2020) Helmut Sies et al. FREE RADICAL BIOLOGY AND MEDICINE
- Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings
- (2020) Ebrahim Abbasi-Oshaghi et al. International Journal of Surgery
- Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
- (2020) Cintia A. Menéndez et al. Science Advances
- Hematobiochemical Disturbances and Oxidative Stress After Subacute Manganese Chloride Exposure and Potential Protective Effects of Ebselen in Rats
- (2018) Hager Tarek H. Ismail BIOLOGICAL TRACE ELEMENT RESEARCH
- Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission
- (2018) Yogy Simanjuntak et al. PLoS Pathogens
- Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Jonathan Kil et al. LANCET
- Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication
- (2016) Suzie Thenin-Houssier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice
- (2016) L. C. Oostwoud et al. Scientific Reports
- Ebselen Attenuates Lung Injury in Experimental Model of Carrageenan-Induced Pleurisy in Rats
- (2015) Fabricia Petronilho et al. INFLAMMATION
- Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep and Emotional Processing in Humans
- (2015) Nisha Singh et al. NEUROPSYCHOPHARMACOLOGY
- Ebselen Inhibits Hepatitis C Virus NS3 Helicase Binding to Nucleic Acid and Prevents Viral Replication
- (2014) Sourav Mukherjee et al. ACS Chemical Biology
- The early research and development of ebselen
- (2013) Michael J. Parnham et al. BIOCHEMICAL PHARMACOLOGY
- Ebsulfur Is a Benzisothiazolone Cytocidal Inhibitor Targeting the Trypanothione Reductase ofTrypanosoma brucei
- (2013) Jun Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started